| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 108 |
| 1 | TACROLIMUS | 72 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 69 |
| 3 | TACROLIMUS OINTMENT 0.1% | 69 |
| 4 | MYCOPHENOLATE MOFETIL | 68 |
| 5 | CYCLOSPORINE | 39 |
| 6 | METHOTREXATE SODIUM | 35 |
| 7 | METHOTREXATE | 33 |
| 8 | METHYLPREDNISOLONE | 27 |
| 9 | AZATHIOPRINE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZNIDAZOLE | 16 | 0.1569 |
| 1 | CARMUSTINE | 6 | 0.0013 |
| 2 | AXICABTAGENE CILOLEUCEL | 10 | 0.0010 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 7 | 0.0009 |
| 4 | MYCOPHENILIC ACID | 16 | 0.0007 |
| 5 | MYCOPHENOLIC ACID | 18 | 0.0005 |
| 6 | TACROLIMUS OINTMENT 0.1% | 69 | 0.0005 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 69 | 0.0005 |
| 8 | VALGANCICLOVIR | 10 | 0.0005 |
| 9 | SIROLIMUS | 7 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 139 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 39 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 3 | Purine Antimetabolite [EPC] | 25 |
| 4 | Alkylating Drug [EPC] | 22 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 16 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 8 | Thalidomide Analog [EPC] | 16 |
| 9 | Kinase Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 10 | 0.0010 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 16 | 0.0007 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 12 | 0.0005 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 39 | 0.0003 |
| 5 | Purine Antimetabolite [EPC] | 25 | 0.0003 |
| 6 | Polyene Antifungal [EPC] | 10 | 0.0002 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Corticosteroid [EPC] | 139 | 0.0001 |